BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30542507)

  • 1.
    Rios-Fuller TJ; Ortiz-Soto G; Lacourt-Ventura M; Maldonado-Martinez G; Cubano LA; Schneider RJ; Martinez-Montemayor MM
    Oncotarget; 2018 Nov; 9(89):35907-35921. PubMed ID: 30542507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 as a promising chemoresistance biomarker associated with the CD44
    Moreira MP; da Conceição Braga L; Cassali GD; Silva LM
    Exp Cell Res; 2018 Feb; 363(2):283-290. PubMed ID: 29352988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Betavulgarin Isolated from Sugar Beet (
    Liu R; Choi HS; Zhen X; Kim SL; Kim JH; Ko YC; Yun BS; Lee DS
    Molecules; 2020 Jun; 25(13):. PubMed ID: 32630026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting of the Eukaryotic Translation Initiation Factor 4A Against Breast Cancer Stemness.
    Sridharan S; Robeson M; Bastihalli-Tukaramrao D; Howard CM; Subramaniyan B; Tilley AMC; Tiwari AK; Raman D
    Front Oncol; 2019; 9():1311. PubMed ID: 31867270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition.
    Oh E; Kim YJ; An H; Sung D; Cho TM; Farrand L; Jang S; Seo JH; Kim JY
    Int J Cancer; 2018 Oct; 143(8):1978-1993. PubMed ID: 29744876
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Acevedo-Díaz A; Ortiz-Soto G; Suárez-Arroyo IJ; Zayas-Santiago A; Martínez Montemayor MM
    Nutrients; 2019 May; 11(5):. PubMed ID: 31109134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network pharmacology analysis of the anti-cancer pharmacological mechanisms of Ganoderma lucidum extract with experimental support using Hepa1-6-bearing C57 BL/6 mice.
    Zhao RL; He YM
    J Ethnopharmacol; 2018 Jan; 210():287-295. PubMed ID: 28882624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor Effect of Ganoderma lipsiense Extract on Triple-negative Breast Cancer Model Mice and Mechanism Study].
    Qi ZH; Meng J; Wang ZL; Sun HZ; Gong Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Mar; 36(3):366-9. PubMed ID: 27236898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors.
    Yang F; Cao L; Sun Z; Jin J; Fang H; Zhang W; Guan X
    Int J Biol Sci; 2016; 12(12):1568-1577. PubMed ID: 27994520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.
    Kagara N; Huynh KT; Kuo C; Okano H; Sim MS; Elashoff D; Chong K; Giuliano AE; Hoon DS
    Am J Pathol; 2012 Jul; 181(1):257-67. PubMed ID: 22626806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes
    Olsson M; Larsson P; Johansson J; Sah VR; Parris TZ
    Front Cell Dev Biol; 2023; 11():1237673. PubMed ID: 37771376
    [No Abstract]   [Full Text] [Related]  

  • 12. Protein tyrosine phosphatase receptor-type δ acts as a negative regulator suppressing breast cancer.
    Yu X; Zhang F; Mao J; Lu Y; Li J; Ma W; Fan S; Zhang C; Li Q; Wang B; Song B; Li L
    Oncotarget; 2017 Nov; 8(58):98798-98811. PubMed ID: 29228728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer.
    Tian J; Hachim MY; Hachim IY; Dai M; Lo C; Raffa FA; Ali S; Lebrun JJ
    Sci Rep; 2017 Jan; 7():40258. PubMed ID: 28054666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3 correlates with stem cell-related transcription factors in cervical cancer.
    Wang H; Cai HB; Chen LL; Zhao WJ; Li P; Wang ZQ; Li Z
    J Huazhong Univ Sci Technolog Med Sci; 2015 Dec; 35(6):891-897. PubMed ID: 26670442
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Liu X; Xu Y; Li Y; Pan Y; Sun Z; Zhao S; Hou Y
    Am J Transl Res; 2020; 12(6):2675-2684. PubMed ID: 32655799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A supercritical-CO2 extract of Ganoderma lucidum spores inhibits cholangiocarcinoma cell migration by reversing the epithelial-mesenchymal transition.
    Li L; Guo HJ; Zhu LY; Zheng L; Liu X
    Phytomedicine; 2016 May; 23(5):491-7. PubMed ID: 27064008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Breast Cancer Stem Cells in Chemoresistance and Metastasis in Triple-Negative Breast Cancer.
    He L; Wick N; Germans SK; Peng Y
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganoderma lucidum extract inhibits proliferation of SW 480 human colorectal cancer cells.
    Xie JT; Wang CZ; Wicks S; Yin JJ; Kong J; Li J; Li YC; Yuan CS
    Exp Oncol; 2006 Mar; 28(1):25-9. PubMed ID: 16614703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin.
    Kai M; Kanaya N; Wu SV; Mendez C; Nguyen D; Luu T; Chen S
    Breast Cancer Res Treat; 2015 Jun; 151(2):281-94. PubMed ID: 25904215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALDH1+ stem cells demonstrate more stem cell-like characteristics than CD44
    Chen J; Liu S; Su Y; Zhang X
    Transl Cancer Res; 2020 Mar; 9(3):1652-1659. PubMed ID: 35117513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.